US divestment in global health: disruption, uncertainty and response.
Uloženo v:
| Název: | US divestment in global health: disruption, uncertainty and response. |
|---|---|
| Autoři: | Franz C; Department of Population Medicine and Health Services Research, School of Public Health, Bielefeld University, Bielefeld, Nordrhein-Westfalen, Germany c.franz@uni-bielefeld.de.; CPC Analytics, Berlin, Berlin, Germany., Bozorgmehr K; Department of Population Medicine and Health Services Research, School of Public Health, Bielefeld University, Bielefeld, Nordrhein-Westfalen, Germany.; Section Health Equity Studies & Migration, University Hospital Heidelberg, Heidelberg, Baden-Württemberg, Germany. |
| Zdroj: | BMJ global health [BMJ Glob Health] 2025 Nov 16; Vol. 10 (11). Date of Electronic Publication: 2025 Nov 16. |
| Způsob vydávání: | Journal Article; Review |
| Jazyk: | English |
| Informace o časopise: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101685275 Publication Model: Electronic Cited Medium: Print ISSN: 2059-7908 (Print) Linking ISSN: 20597908 NLM ISO Abbreviation: BMJ Glob Health Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: [London] : BMJ Publishing Group Ltd, [2016]- |
| Výrazy ze slovníku MeSH: | Global Health*/economics , International Cooperation*, United States ; Humans ; Uncertainty ; Politics |
| Abstrakt: | Competing Interests: Competing interests: CF has advised the WHO Hub for Pandemic and Epidemic Intelligence through his work at CPC Analytics. KB has been a consultant to the WHO European Regional Office, the WHO Headquarters and the IOM. The authors declare that they have no conflict of interest. The decisions of the US administration under Donald Trump in January 2025 to divest from many development activities have severely disrupted the state of affairs in global health. We analyse the extent of this disruption from two perspectives. First, we show that about 45 out of every 100 dollars spent on global health from 2019 to 2022 came from the US. Using data on bilateral official development assistance for health from the US, we identify recipient countries and health areas that will be most affected. We demonstrate differential sectoral impacts in more than a dozen countries-mainly within WHO's Africa region-which have been heavily reliant on US aid and other external sources to fund their health services. Severe fiscal constraints and/or ongoing conflicts and fragility in these countries further exacerbate potential impacts. Second, we analyse US contributions to UN organisations and other multilateral bodies most relevant to global health. This combined analysis provides a baseline for countries and organisations to understand the immediate financial fallout and the future risks within a changed global health financing system. (© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.) |
| References: | Lancet Glob Health. 2025 Oct;13(10):e1669-e1680. (PMID: 40975076) Nat Med. 2025 Mar;31(3):719. (PMID: 39929987) Prev Med. 2018 Mar;108:17-22. (PMID: 29288780) BMJ. 2025 Jan 20;388:r116. (PMID: 39837635) Lancet. 2025 Feb 8;405(10477):514-516. (PMID: 39889719) Int J Equity Health. 2014 Oct 10;13:68. (PMID: 25928731) BMJ. 2025 Sep 9;390:r1890. (PMID: 40925664) Lancet. 2025 Feb 22;405(10479):603-605. (PMID: 39929219) PLOS Glob Public Health. 2024 Apr 11;4(4):e0002928. (PMID: 38602939) PLoS Med. 2021 Apr 22;18(4):e1003604. (PMID: 33886540) Lancet HIV. 2025 Aug;12(8):e543. (PMID: 40543516) BMJ. 2025 Feb 27;388:r392. (PMID: 40015742) Lancet. 2025 Jul 19;406(10500):283-294. (PMID: 40609560) BMJ. 2025 Mar 11;388:r468. (PMID: 40068843) Lancet. 2025 Feb 8;405(10477):439. (PMID: 39922658) BMJ. 2025 Feb 12;388:r294. (PMID: 39938945) Int J Health Policy Manag. 2022 Aug 1;11(8):1246-1250. (PMID: 35942959) BMJ. 2024 Dec 17;387:q2708. (PMID: 39689965) Lancet. 2025 Sep 27;406(10510):1320-1322. (PMID: 40972624) BMJ Glob Health. 2023 Nov 24;8(11):. (PMID: 38007225) BMJ. 2025 May 22;389:r1066. (PMID: 40404310) PLOS Glob Public Health. 2023 Dec 8;3(12):e0002663. (PMID: 38064490) Science. 2025 Aug 28;389(6763):862-863. (PMID: 40875835) Nat Med. 2025 Sep;31(9):3101-3109. (PMID: 40866582) PLOS Glob Public Health. 2025 Sep 10;5(9):e0004899. (PMID: 40929049) Lancet. 2024 Dec 7;404(10469):2258-2260. (PMID: 39645375) |
| Contributed Indexing: | Keywords: Global Health; Health economics; Health policy |
| Entry Date(s): | Date Created: 20251117 Date Completed: 20251117 Latest Revision: 20251120 |
| Update Code: | 20251121 |
| PubMed Central ID: | PMC12625848 |
| DOI: | 10.1136/bmjgh-2025-019990 |
| PMID: | 41248938 |
| Databáze: | MEDLINE |
Full Text 
Full Text Finder 
Nájsť tento článok vo Web of Science | Abstrakt: | Competing Interests: Competing interests: CF has advised the WHO Hub for Pandemic and Epidemic Intelligence through his work at CPC Analytics. KB has been a consultant to the WHO European Regional Office, the WHO Headquarters and the IOM. The authors declare that they have no conflict of interest.<br />The decisions of the US administration under Donald Trump in January 2025 to divest from many development activities have severely disrupted the state of affairs in global health. We analyse the extent of this disruption from two perspectives. First, we show that about 45 out of every 100 dollars spent on global health from 2019 to 2022 came from the US. Using data on bilateral official development assistance for health from the US, we identify recipient countries and health areas that will be most affected. We demonstrate differential sectoral impacts in more than a dozen countries-mainly within WHO's Africa region-which have been heavily reliant on US aid and other external sources to fund their health services. Severe fiscal constraints and/or ongoing conflicts and fragility in these countries further exacerbate potential impacts. Second, we analyse US contributions to UN organisations and other multilateral bodies most relevant to global health. This combined analysis provides a baseline for countries and organisations to understand the immediate financial fallout and the future risks within a changed global health financing system.<br /> (© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.) |
|---|---|
| ISSN: | 2059-7908 |
| DOI: | 10.1136/bmjgh-2025-019990 |